⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCRX News
BioCryst Pharmaceuticals Inc
Form 8-K
sec.gov
BCRX
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
globenewswire.com
BCRX
WCG Appoints Anthony Doyle as Chief Financial Officer to Support Continued Growth and Operational Scale
prnewswire.com
BCRX
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCRX
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
globenewswire.com
BCRX
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events
businesswire.com
BCRX
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
globenewswire.com
BCRX
Hereditary angioedema, a European initiative to shine a spotlight on a still under-recognized condition
prnewswire.com
BCRX
Form 8-K
sec.gov
BCRX
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
BCRX